Delivery Order SPE2DB24D2213-SPE2DB24FGVUJ

Award Date 9/17/24
Potential Completion Date 10/8/24
Potential Value $4.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract valued at $13,971.12 to Amerisourcebergen Drug Corp for the supply of 200 unit vials of BOTOX. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999, for the provision of a wide range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The...
The U.S. Defense Logistics Agency (DLA) awarded a $61,123.65 Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp, Corporate Office Division, for the supply of 200-unit vials of BOTOX. This award is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999 through December 2025, for delivering a wide range of pharmaceutical and medical supplies to support military treatment programs and...
The U.S. Defense Logistics Agency (DLA) awarded a $5,821.30 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,594,222 units of BOTOX 200 unit vials. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 200 unit vials of BOTOX. The $11,642.60 contract has a completion date of March 6, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor on this delivery order as well as an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 through December 31,...
The U.S. Defense Logistics Agency (DLA) awarded a $29,106.50 firm fixed-price delivery order contract (SPE2DB22D3004|SPE2DB24FRV73) to Amerisourcebergen Drug Corp's Corporate Office division for the supply of 200-unit vials of BOTOX. The contract has an ultimate completion date of October 7, 2024. As a major pharmaceutical distributor, Amerisourcebergen has been awarded numerous indefinite delivery contracts (IDCs) by the DLA Troop Support Medical and the Department of Justice Federal Bureau...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the provision of 200 unit vials of Botox. The firm-fixed-price contract is valued at $3,492.78 and has a period of performance through July 19, 2024. Amerisourcebergen, a major pharmaceutical distribution company, leverages its extensive supply chain to fulfill government contracts, particularly for the Department of Defense (DoD) and Veterans Affairs (VA)...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order worth $2,328.52 to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The order is for 200-unit vials of the prescription drug BOTOX and is a Firm Fixed Price contract with a completion date of May 8, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the federal government, particularly the Department of Defense...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $58,213 contract is for the delivery of 200-unit vials of BOTOX medication to support military treatment programs and facilities. This delivery order is issued under Amerisourcebergen's existing indefinite delivery contract (IDC) with DLA valued at up to $999,999,999 through...
The U.S. Defense Logistics Agency (DLA) awarded a $61,123.65 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4,564,667,812 units of BOTOX 200 unit vials. This order is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of BOTOX 100 unit vials. The $4,306.80 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of February 20, 2025. The contract is not set aside for any particular business type. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
  • SPE2DB24D2213
    Indefinite Delivery Contract
  • SPE2DB24D2213-SPE2DB24FGVUJ
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $4,657.04 Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp for the supply of 200-unit vials of BOTOX. This contract has an ultimate completion date of October 8, 2024. Amerisourcebergen, a major pharmaceutical distributor, provides a wide range of medical commodities and prescription drugs to support various federal agencies and healthcare programs. The company holds Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999 and $750,000 respectively, to deliver essential pharmaceutical and medical supplies to military treatment facilities, veterans' hospitals, and other federal healthcare providers.

Generated 12/17/24, 9:27 AM